Associate Professor in Radiology, Northwestern University Medical School
Radiology
Dr. Robert Lewandowski, MD
|
|
Give Review
Robert Lewandowski practices Radiology. He has 1 awards "Fellow (FSIR)". Robert Lewandowski is a published MD. He published 100 publications, including: 'Commentary on: "Occupational radiation exposure of medical staff performing (90)Y-loaded microsphere radioembolization".' Robert Lewandowski accepts all Medicare patients.
Publications
- SPIO-labeled Yttrium Microspheres for MR Imaging Quantification of Transcatheter Intrahepatic Delivery in a Rodent Model.
- Commentary on: "Occupational radiation exposure of medical staff performing (90)Y-loaded microsphere radioembolization".
- A Comparison of Retrievability: Celect versus Option Filter.
- Transarterial Chemoembolization and Yittrium-90 for Liver Cancer and Other Lesions.
- Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?
- Yttrium-90 Radioembolization is a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases: Further Evidence in Support of a New Tr...
- Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.
- Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
- Comparison of Complication Rates Associated with Permanent and Retrievable Inferior Vena Cava Filters: A Review of the MAUDE Database.
- MR Imaging Enables Measurement of Therapeutic Nanoparticle Uptake in Rat N1-S1 Liver Tumors after Nanoablation.
- Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.
- Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.
- Optimizing the Use of Inferior Vena Cava Filters in Oncology Patients: Are All Filters Created Equally?
- Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.
- Localized Hyperthermia with Iron Oxide-Doped Yttrium Microparticles: Steps toward Image-Guided Thermoradiotherapy in Liver Cancer.
- Outpatient Single-Session Yttrium-90 Glass Microsphere Radioembolization.
- Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.
- Prophylactic Embolization of the Gastroduodenal and Right Gastric Arteries Is Not Routinely Necessary before Radioembolization with Glass Microspheres.
- Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study.
- Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort.
- Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization.
- Cancer concepts and principles: primer for the interventional oncologist-part I.
- Prospective Evaluation of Patients with Early-/Intermediate-stage Hepatocellular Carcinoma with Disease Progression Following Arterial Locoregional Therapy: Candidacy ...
- Image-Guided Local Delivery Strategies Enhance Therapeutic Nanoparticle Uptake in Solid Tumors.
- Cancer Concepts and Principles: Primer for the Interventional Oncologist-Part II.
- Positron Emission Tomography/CT after Yttrium-90 Radioembolization: Current and Future Applications.
- Imaging tumor response following liver-directed intra-arterial therapy.
- Radioembolization of renal cell carcinoma using yttrium-90 microspheres.
- Optional or permanent: clinical factors that optimize inferior vena cava filter utilization.
- Response assessment methodologies in hepatocellular carcinoma: Complexities in the era of local and systemic treatments.
- Radioembolization for hepatocellular carcinoma with portal Vein thrombosis: impact of liver function on systemic treatment options at disease progression.
- Yttrium-90 radioembolization for the treatment of unresectable hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
- Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
- Intraprocedural Transcatheter Intra-arterial Perfusion MRI as a Predictor of Tumor Response to Chemoembolization for Hepatocellular Carcinoma.
- Transcatheter intraarterial therapies: rationale and overview.
- Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times.
- Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.
- Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
- Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.
- Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization.
- Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic.
- Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction.
- MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.
- How to interpret thyroid biopsy results: a three-year retrospective interventional radiology experience.
- Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis.
- Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.
- Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine Artery embolization in the rabbit VX2 tumor model.
- Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma.
- Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.
- Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yt...
- Yttrium-90 radioembolization in the management of liver malignancies.
- Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.
- Direct hepatic Artery puncture for transarterial therapy in liver cancer.
- A simple fluoroscopic approach to percutaneous transgastric cystgastrostomy with internalized drainage catheter for treatment of pancreatic pseudocysts: report of two ...
- Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival.
- Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
- Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.
- Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
- The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.
- Radiologic findings following Y90 radioembolization for primary liver malignancies.
- Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.
- Development of a VX2 pancreatic cancer model in rabbits: a pilot study.
- Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
- Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
- Respiratory self-gating for free-breathing Abdominal phase-contrast blood flow measurements.
- Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres.
- MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study.
- Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.
- Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments.
- Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
- Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
- Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.
- 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
- Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs.
- MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
- Biliary sequelae following radioembolization with Yttrium-90 microspheres.
- Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
- Thoracic duct embolization: a new treatment for massive leak after neck dissection.
- Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
- Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal Vein thrombosis.
- Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.
- Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
- A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
- Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors.
- Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit ...
- Radioembolization with 90Y microspheres: angiographic and technical considerations.
- 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
- Technical aspects of radioembolization with 90Y microspheres.
- Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
- Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma.
- Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization.
- Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver.
- 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured b...
- Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
- Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic im...
- The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
- Angiographic considerations in patients undergoing liver-directed therapy.
- Electroporation-mediated transcatheter arterial chemoembolization in the rabbit VX2 liver tumor model.
- Radioembolization for primary and metastatic liver cancer.
Schools
Michigan State University
Procedures Preformed
- Vascular Duplex Ultrasonography and Plethysmography
Conditions Treated
- Abdominal Aortic Aneurysm (AAA)
- Acute Deep Vein Thrombosis (DVT)
- Acute Venous Embolism Thrombosis
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Interventional Radiology
- Radiology
Accepted Insurances
Awards
- Fellow (FSIR)
Education
-
McGaw Medical Center of Northwestern University -
William Beaumont Hospital -
Virginia Mason Medical Center -
Michigan State University College of Human Medicine
Hospital
-
Northwestern Memorial Hospital -
Jesse Brown Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1689618761 | |
| NPPES Provider LastName | LEWANDOWSKI | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 606114546 | |
| NPPES Provider State | IL | |
| Specialty Description | Diagnostic Radiology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689618761 |
| Last Name Of The Provider | LEWANDOWSKI |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
Dr. Elias S. Hohlastos, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh Amble, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ron C. Gaba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard Chrisman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Bui, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yari Cohen, MD |
|
|
Dr. Vincent B. Rowley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anil K. Pillai, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert K. Ryu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Riad Salem, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nathaniel O. Holloway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renato Ripamonti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth D. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sudeep H. Bhabad, MD |
|
|
Dr. Frank M. Marmo, MD
This Doctor is OpenDoctor Recommended.
|